NCT05711667 2026-02-24A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric PatientsChildren's Oncology GroupPhase 3 Recruiting105 enrolled
NCT06449586 2025-12-15CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCTRuijin HospitalPhase 3 Active not recruiting250 enrolled